All GLP-1 therapy requires ongoing medical monitoring to assess response, manage side effects, and ensure appropriate continuation or discontinuation based on individual outcomes
Safety Monitoring and Provider Decision Framework Patients with both RA and obesity or type 2 diabetesconditions for which GLP-1 medications are indicatedmay benefit from GLP-1 therapy, but initiation should involve coordination between rheumatology and primary care or endocrinology
If you are planning surgery or medical procedures , follow the specific advice from your surgical team regarding when to stop GLP-1 medications
How PlexusDx Supports a More Personalized Approach PlexusDx recognizes that GLP-1 selection involves both clinical criteria and emerging biomarker considerations
If your existing diabetic retinopathy worsens after starting Ozempic, our ophthalmologists will develop a treatment plan tailored to your situation
What tier is Ozempic on BCBSNC formularies